NCT06473376

Brief Summary

This prospective, randomized control study aimed to compare the Clinical Outcome of Hegab splint, Arthrocentesis, and Arthroscopy in treatment of TMJ closed lock. The study sample was derived from the population of patients who presented for evaluation and treatment of TMJ disorders.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
45

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2020

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 14, 2020

Completed
3.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 30, 2023

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2023

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

June 18, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

June 25, 2024

Completed
Last Updated

June 25, 2024

Status Verified

June 1, 2024

Enrollment Period

3.5 years

First QC Date

June 18, 2024

Last Update Submit

June 23, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • change in pain using a visual analog scale,

    The primary outcome variable was the change in pain using a visual analog scale (VAS), with 0 indicating the absence of pain and 10 indicating the worst pain possible

    one year

  • improvement of maximum voluntary mouth opening

    improvement of maximum voluntary (non-assisted) mouth opening (MVMO) in millimetres.

    one year

Study Arms (3)

Group I (Control)

OTHER

Hegab TMJ splint

Procedure: arthrocentesis

Group II

OTHER

arthrocentesis

Procedure: arthrocentesis

GROUP III

OTHER

arthroscopy

Procedure: arthrocentesis

Interventions

TMJ arthrocentesis and arthroscopy

Also known as: arthroscopy
GROUP IIIGroup I (Control)Group II

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Patients with TMJ closed lock confirmed

You may not qualify if:

  • rheumatoid arthritis psoriatic arthritis juvenile arthritis those receiving anticoagulant therapy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Al-Azhar UNIVERSITY

Cairo, Egypt

Location

Prof.Hegab

Cairo, Egypt

Location

MeSH Terms

Conditions

Temporomandibular Joint Disorders

Interventions

ArthrocentesisArthroscopy

Condition Hierarchy (Ancestors)

Craniomandibular DisordersMandibular DiseasesJaw DiseasesMusculoskeletal DiseasesJoint DiseasesMuscular DiseasesStomatognathic Diseases

Intervention Hierarchy (Ancestors)

ParacentesisSpecimen HandlingClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisPuncturesTherapeuticsSurgical Procedures, OperativeInvestigative TechniquesEndoscopyDiagnostic Techniques, SurgicalMinimally Invasive Surgical ProceduresOrthopedic Procedures

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: The patients were randomly assigned to one of the following three groups: Group I (Control): patients treated by Hegab splint. Group II: patients treated by arthrocentesis with injection of HA/PRP mix plus Hegab splint. Group III: arthroscopy with injection of HA/PRP mix plus Hegab splint. The primary outcome variable was the change in pain using a visual analog scale, and improvement of maximum voluntary mouth opening. The secondary outcome variable was the change in joint sound. The third category of variables (age and sex) was evaluated in relation to the outcomes
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof. Ayman Hegab

Study Record Dates

First Submitted

June 18, 2024

First Posted

June 25, 2024

Study Start

January 14, 2020

Primary Completion

July 30, 2023

Study Completion

December 30, 2023

Last Updated

June 25, 2024

Record last verified: 2024-06

Data Sharing

IPD Sharing
Will not share

Locations